Varicose veins could be a sign of CANCER, doctors warn - after treating 53-year-old woman with aggressive lymphoma
Doctors are warning that varicose veins could be a commonly missed sign of an aggressive form of non-Hodgkin lymphoma after treating a 53-year-old woman in China with the symptoms. (Source: the Mail online | Health)
Source: the Mail online | Health - December 8, 2023 Category: Consumer Health News Source Type: news
PET/CT predicts patient responses to CAR-T cell therapy
F-18 FDG-PET/CT scans may predict outcomes in patients with large B cell lymphoma undergoing chimeric antigen receptor (CAR) T-cell therapy, according to a presentation delivered November 30 at RSNA. Doris Leithner, MD, of Memorial Sloan-Kettering Cancer Center in New York City, presented a study in which researchers explored whether F-18 FDG-PET/CT imaging features acquired prior to treatment with CAR T-cell therapy were related to patient outcomes. They found the imaging features were strongly associated with death, relapse, and disease progression.“Our results demonstrate that quantitative PET imaging features in LBCL...
Source: AuntMinnie.com Headlines - December 4, 2023 Category: Radiology Authors: Will Morton Tags: Nuclear Radiology Source Type: news
Poor Physical Function Persists in Childhood Cancer Survivors
MONDAY, Nov. 20, 2023 -- Despite changes in therapy, the prevalence of poor physical function has remained steady among childhood survivors of acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL), according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2023 Category: Pharmaceuticals Source Type: news
Was This a Recurrence of Non-Hodgkin ’s Lymphoma or Something Else?
“Go to the emergency room,” the doctor told him after hearing of his trip and fever, rash and whole-body weakness. “You need to be seen.” (Source: NYT Health)
Source: NYT Health - November 20, 2023 Category: Consumer Health News Authors: Lisa Sanders, M.D. Tags: Chikungunya Virus Non-Hodgkin ' s Lymphoma Lyme Disease Joints (Body Part) Source Type: news
First in human trial of new drug raises hopes for patients with relapsed blood cancer
A new targeted drug, studied by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James), may offer a new treatment option for patients with blood cancers, including chronic lymphocytic leukemia (CLL) and Non-Hodgkin lymphoma (NHL) whose disease has stopped responding to standard treatments. (Source: World Pharma News)
Source: World Pharma News - November 6, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
PD-1 Inhibitor Improves Outcomes in NHL Subtype PD-1 Inhibitor Improves Outcomes in NHL Subtype
Treatment with the PD-1 inhibitor toripalimab plus radiation therapy improved outcomes in patients with a subtype of non-Hodgkin lymphoma, new data show.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 1, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Non-Hodgkin Lymphoma Highlights From SOHO 2023 Non-Hodgkin Lymphoma Highlights From SOHO 2023
Dr Loretta Nastoupil highlights key data in non-Hodgkin lymphoma from SOHO 2023, including safety and efficacy of CAR-T therapies, bispecific antibodies, and mosunetuzumab retreatment.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 27, 2023 Category: Consumer Health News Tags: Hematology-Oncology ReCAP Source Type: news
McConnell ’ s Bid to Downplay Freezes Undermined by History of Politicians Lying About Their Health
After Senate Minority Leader Mitch McConnell froze during a press conference this month, the Kentucky Republican’s second such episode this summer, his office released a note from the Capitol physician intended to calm those worried about his ability to continue at his job.
Dr. Brian Monahan told McConnell in the letter that there was “no evidence that you have a seizure disorder or that you experienced a stroke, TIA or movement disorder such as Parkinson’s disease.” Monahan suggested the episodes may be related to the Leader’s concussion in March or to dehydration.
[time-brightcove n...
Source: TIME: Health - September 11, 2023 Category: Consumer Health News Authors: Mini Racker Tags: Uncategorized Congress Source Type: news
I was diagnosed with terminal non-Hodgkin's lymphoma cancer aged 20 despite being in peak physical condition - I mistook my symptoms as burnout
Lee Troutman, from Georgia, was diagnosed with late-stage lymphoma last year after suffering from night sweats, fatigue, and liver pain. Before diagnosis, he had worked out 12 hours a day. (Source: the Mail online | Health)
Source: the Mail online | Health - September 6, 2023 Category: Consumer Health News Source Type: news
Response: Alternative approaches for systematic review - Goodman JE, Ticknor RC, Zhou J.
We appreciate the opportunity to respond to the commentaries on our paper, "Systematic Review of Perchloroethylene and Non Hodgkin's Lymphoma." [1] As noted by LaKind et al. [2], there are an overwhelming number of systematic review frameworks, many of whi... (Source: SafetyLit)
Source: SafetyLit - September 1, 2023 Category: International Medicine & Public Health Tags: Research Methods, Surveillance and Codes, Models Source Type: news
Student, 22, hit with 'shock' cancer diagnosis shares the first warning sign
The 22-year-old student shared the first symptom of her non-Hodgkin lymphoma struck in her armpit. (Source: Daily Express - Health)
Source: Daily Express - Health - August 28, 2023 Category: Consumer Health News Source Type: news
CAR-T Therapy for NHL Treats Concurrent Rheumatic Disease CAR-T Therapy for NHL Treats Concurrent Rheumatic Disease
CAR –T cell therapy for non-Hodgkin lymphoma appeared as safe and effective in patients with rheumatic autoimmune disease as in those without and also improved control of the underlying autoimmunity.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - August 24, 2023 Category: Allergy & Immunology Tags: Rheumatology Source Type: news
At age 29 I've survived terminal brain cancer, blood cancer AND a near-fatal car crash
Aria, from Los Angeles, was diagnosed with non-Hodgkins lymphoma, a blood cancer, and underwent 16 brutal surgeries and multiple rounds of chemo, starting her ordeal. (Source: the Mail online | Health)
Source: the Mail online | Health - August 3, 2023 Category: Consumer Health News Source Type: news
At age 28 I've survived terminal brain tumor, blood cancer AND a near-fatal car crash... that's why I call myself the 'CEO of not dying'
Aria, from Los Angeles, was diagnosed with non-Hodgkins lymphoma, a blood cancer, and underwent 16 brutal surgeries and multiple rounds of chemo, starting her ordeal. (Source: the Mail online | Health)
Source: the Mail online | Health - July 27, 2023 Category: Consumer Health News Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in both divisions ’ base business; Group sales and profit reflect declining demand for COVID-19 products
Excluding COVID-19 products,Groupsales increase strongly by 8%1at constant exchange rates (CER)In line with the expected declining demand for COVID-19 products,Groupsales decrease 2% (-8% in Swiss francs)Pharmaceuticals Division sales grow strongly by 8% due to continued high demand for newer medicines; new eye medicine Vabysmo is the strongest growth driverDiagnostics Division ’s base businesscontinues its good growth momentum with an increase of 6%, while total divisional sales are 23% lower due to exceptionally high demand for COVID-19 tests in the first half of 2022Core earnings per share decrease 5%, driven by lower...
Source: Roche Investor Update - July 27, 2023 Category: Pharmaceuticals Source Type: news
